In this Issue:
Prostate cancer detection with MR-ultrasound fusion biopsy
Hypofractionated radiotherapy for prostate cancer
Re-evaluating PLCO trial PSA testing rates
Robotic prostatectomy and US urologists’ practice patterns
Immune checkpoint regulator PD-L1 in primary prostate cancer
Genomic changes in cell-free DNA and enzalutamide resistance
AS guidelines for localised prostate cancer
Saturated fat intake and prostate cancer aggressiveness
Docetaxel plus androgen deprivation therapy
Please login below to download this issue (PDF)